ArticleFrontiers in physiology2025
Computational modeling of cough-induced droplets and mucosal film dynamics in the upper airway for pulmonary disease classification.
Article in Frontiers in physiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Experimentally Informed Numerical Simulations of Spray Deposition and Runoff Doses in a 10-Day-Old Nose Model.Pharmaceuticals (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Cough-generated droplets are critical in the transmission and progression of respiratory diseases. This study investigates droplet formation and transport in the upper airway during a cough to improve understanding of their biomechanical behavior and explore their potential for non-invasive classification of airway diseases. Methods: A computational fluid dynamics model is employed to simulate a transient, droplet-laden cough in a CT-derived human upper airway, using an experimentally acquired cough profile. The method incorporates mucus film dynamics using the Eulerian Wall Film (EWF) model and droplet transport using the Discrete Phase Model (DPM). Three mucus thicknesses-healthy baseline (Type I), intermediate pathological thickening (Type II), and advanced pathological thickening (Type III)-and three viscosity levels for Type II: baseline viscosity (Type II-A), intermediate viscosity (Type II-B), and high viscosity (Type II-C) are considered. These cases represent a progressive increase in both mucus thickness and viscosity, encompassing a spectrum of respiratory conditions. Results: The results show that a 50% increase in mucus thickness (from 20 μm to 30 μm) results in 4.3-fold increase in exhaled droplet count and a 20% increase in mean droplet size. Conversely, a 50% increase in mucus viscosity reduces exhaled droplet count by 2.7-fold while increasing mean droplet size by 9%. Absorbed droplets, which remain within the airway, exhibit similar trends; however, as they are not measurable non-invasively, their diagnostic utility is limited. Discussion: These findings highlight the role of mucus in droplet dynamics, with increased thickness and viscosity driving larger droplet sizes, with increased thickness and viscosity driving larger droplet sizes, and support the potential of exhaled droplet size distribution as a diagnostic biomarker for airway disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.